Tepa

Tepa

SCHEMBL7918394

O=P(N1CC1)(N1CC1)N1CC1.S=P(N1CC1)(N1CC1)N1CC1

nearest known ligand 0.69

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB11 O95342 1/20 0.69
LMNA P02545 1/20 0.69
CHRM2 P08172 1/20 0.69
CYP3A4 P08684 1/20 0.69
ADRA2A P08913 1/20 0.69
CHRM1 P11229 1/20 0.69
DRD2 P14416 1/20 0.69
HPGD P15428 1/20 0.69
ADRA2B P18089 1/20 0.69
ADRA2C P18825 1/20 0.69
CHRM3 P20309 1/20 0.69
CYP2B6 P20813 1/20 0.69
SLC6A2 P23975 1/20 0.69
HTR2A P28223 1/20 0.69
HTR2C P28335 1/20 0.69
SLC6A4 P31645 1/20 0.69
ADRA1A P35348 1/20 0.69
HRH1 P35367 1/20 0.69
OPRM1 P35372 1/20 0.69
DRD3 P35462 1/20 0.69

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tepa SCHEMBL11572 0.83 ABCB11 (0.38) ABCB11LMNACHRM2CYP3A4ADRA2A
Thiotepa SCHEMBL20508912 0.83 ABCB11 (1.00) ABCB11LMNACHRM2CYP3A4ADRA2A
Thiotepa SCHEMBL4760 0.83 ABCB11 (1.00) ABCB11LMNACHRM2CYP3A4ADRA2A
SCHEMBL31153244 0.71 LMNA (0.73) ABCB11LMNACHRM2CYP3A4ADRA2A
SCHEMBL535105 0.69 MEN1 (0.46) LMNA
SCHEMBL3084917 0.69 ABCB11 (0.71) ABCB11LMNACHRM2CYP3A4ADRA2A
SCHEMBL1276982 0.67 KMT2A (0.50) LMNA
SCHEMBL434983 0.67 HPGD (0.65) ABCB11LMNACHRM2CYP3A4ADRA2A
SCHEMBL1276983 0.62 MAPT (0.46) SMN1; SMN2
SCHEMBL11392242 0.62 ABCB11 (0.59) ABCB11LMNACHRM2CYP3A4ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6221383-B1 BLEND OF AT LEAST TWO POLYMERS, OR AT LEAST ONE POLYMER AND A SOLUBLE POLYVINYLPYRROLIDONE, IN COMBINATION WITH A DRUG PROVIDES A PRESSURE-SENSITIVE ADHESIVE COMPOSITION FOR A TRANSDERMAL DRUG DELIVERY SYSTEM NOVEN PHARMACEUTICALS, INC. 2001-04-24 US disclosed